TGM-312

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameTGM-312
Drug Alias NameTGM-312TGM-312-SC01ETX-312
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferenceN-acetylgalactosamine-6-sulfatase modulators
TargetsN-acetylgalactosamine-6-sulfatase
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTangram Therapeutics PlcE-Therapeutics Plc
China Registration ClassN/A

Develop Information

Active CompaniesTangram Therapeutics Plc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A